U.S. Markets close in 3 hrs 32 mins

Did You Miss Genovis's (STO:GENO) Whopping 713% Share Price Gain?

Simply Wall St

For us, stock picking is in large part the hunt for the truly magnificent stocks. You won't get it right every time, but when you do, the returns can be truly splendid. One bright shining star stock has been Genovis AB (publ) (STO:GENO), which is 713% higher than three years ago. But it's down 7.0% in the last week.

We love happy stories like this one. The company should be really proud of that performance!

See our latest analysis for Genovis

We don't think that Genovis's modest trailing twelve month profit has the market's full attention at the moment. We think revenue is probably a better guide. Generally speaking, we'd consider a stock like this alongside loss-making companies, simply because the quantum of the profit is so low. For shareholders to have confidence a company will grow profits significantly, it must grow revenue.

Over the last three years Genovis has grown its revenue at 34% annually. That's well above most pre-profit companies. And it's not just the revenue that is taking off. The share price is up 101% per year in that time. It's always tempting to take profits after a share price gain like that, but high-growth companies like Genovis can sometimes sustain strong growth for many years. So we'd recommend you take a closer look at this one, or even put it on your watchlist.

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

OM:GENO Income Statement, October 13th 2019

It is of course excellent to see how Genovis has grown profits over the years, but the future is more important for shareholders. If you are thinking of buying or selling Genovis stock, you should check out this FREE detailed report on its balance sheet.

What about the Total Shareholder Return (TSR)?

We've already covered Genovis's share price action, but we should also mention its total shareholder return (TSR). The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. We note that Genovis's TSR, at 713% is higher than its share price return of 713%. When you consider it hasn't been paying a dividend, this data suggests shareholders have benefitted from a spin-off, or had the opportunity to acquire attractively priced shares in a discounted capital raising.

A Different Perspective

It's nice to see that Genovis shareholders have received a total shareholder return of 283% over the last year. Since the one-year TSR is better than the five-year TSR (the latter coming in at 59% per year), it would seem that the stock's performance has improved in recent times. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. Before spending more time on Genovis it might be wise to click here to see if insiders have been buying or selling shares.

We will like Genovis better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on SE exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.